Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer.
Sholklapper TN, Creswell ML, Payne AT, Markel M, Pepin A, Carrasquilla M, Zwart A, Danner M, Ayoob M, Yung T, Collins B, Kumar D, Aghdam N, Suy S, Hankins RA, Kowalczyk K, Collins SP. Sholklapper TN, et al. Among authors: zwart a. Front Oncol. 2022 Mar 25;12:852844. doi: 10.3389/fonc.2022.852844. eCollection 2022. Front Oncol. 2022. PMID: 35402242 Free PMC article.
Ejaculatory Function Following Stereotactic Body Radiation Therapy for Prostate Cancer.
Sholklapper T, Creswell M, Cantalino J, Markel M, Zwart A, Danner M, Ayoob M, Yung T, Collins B, Kumar D, Aghdam N, Rubin RS, Hankins R, Suy S, Collins S. Sholklapper T, et al. Among authors: zwart a. J Sex Med. 2022 May;19(5):771-780. doi: 10.1016/j.jsxm.2022.02.018. Epub 2022 Mar 17. J Sex Med. 2022. PMID: 35305936
Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer.
Gallagher L, Xiao J, Hsueh J, Shah S, Danner M, Zwart A, Ayoob M, Yung T, Simpson T, Fallick M, Kumar D, Leger P, Dawson NA, Suy S, Collins SP. Gallagher L, et al. Among authors: zwart a. Front Oncol. 2023 Oct 17;13:1289249. doi: 10.3389/fonc.2023.1289249. eCollection 2023. Front Oncol. 2023. PMID: 37916156 Free PMC article.
Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes.
Carrasquilla M, Sholklapper T, Pepin AN, Hodgins N, Lei S, Rashid A, Danner M, Zwart A, Bolanos G, Ayoob M, Yung T, Aghdam N, Collins B, Suy S, Kumar D, Hankins R, Kowalczyk K, Dawson N, Collins S. Carrasquilla M, et al. Among authors: zwart a. Front Oncol. 2023 Nov 23;13:1240939. doi: 10.3389/fonc.2023.1240939. eCollection 2023. Front Oncol. 2023. PMID: 38074646 Free PMC article.
Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer.
Repka MC, Sholklapper T, Zwart AL, Danner M, Ayoob M, Yung T, Lei S, Collins BT, Kumar D, Suy S, Hankins RA, Kishan AU, Collins SP. Repka MC, et al. Among authors: zwart al. Front Oncol. 2024 Mar 22;14:1381134. doi: 10.3389/fonc.2024.1381134. eCollection 2024. Front Oncol. 2024. PMID: 38585005 Free PMC article.
Impact of neoadjuvant relugolix on patient-reported sexual function and bother.
Hsueh JY, Gallagher L, Koh MJ, Eden S, Shah S, Wells M, Danner M, Zwart A, Ayoob M, Kumar D, Leger P, Dawson NA, Suy S, Rubin R, Collins SP. Hsueh JY, et al. Among authors: zwart a. Front Oncol. 2024 Apr 11;14:1377103. doi: 10.3389/fonc.2024.1377103. eCollection 2024. Front Oncol. 2024. PMID: 38665954 Free PMC article.
181 results